Wikidata:Database reports/Constraint violations/P6531

• Summary
• List of properties
• Property proposal
• Popular properties
• Special:ConstraintReport

Constraint violations report for observed in (Discussion, uses, items, changes, related properties): to be used as reference to location, condition, variant where upon the subject property object statement is based
Data time stamp: 3 December 2023, 11:12 (UTC) — Items processed: 19
The report is generated based on the settings on Property:P6531#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.

"Scope" violations

Violations count: 25

• Agnes Williamsone (Q43391026): charge (P1595): witchcraft (Q259745)
• Agnes Williamsone (Q43391026): charge (P1595): charming (Q65648571)
• Agnes Williamsone (Q43391026): charge (P1595): sorcery (Q9198102)
• Agnes Williamsone (Q43391026): charge (P1595): shapeshifting (Q1925011)
• CSNK1D (Q15324798): increased expression in (P1911): kidney cancer (Q3242950)
• CSNK1D (Q15324798): increased expression in (P1911): bladder carcinoma (Q18556149)
• CSNK1D (Q15324798): increased expression in (P1911): brain cancer (Q9303627)
• CSNK1D (Q15324798): increased expression in (P1911): breast cancer (Q128581)
• CSNK1D (Q15324798): increased expression in (P1911): colorectal cancer (Q188874)
• CSNK1D (Q15324798): increased expression in (P1911): adenocarcinoma of the lung (Q843799)
• CSNK1D (Q15324798): increased expression in (P1911): melanoma (Q180614)
• CSNK1D (Q15324798): increased expression in (P1911): ovarian cancer (Q172341)
• CSNK1D (Q15324798): increased expression in (P1911): pancreatic cancer (Q212961)
• CSNK1D (Q15324798): increased expression in (P1911): lymphoma (Q208414)
• CSNK1D (Q15324798): increased expression in (P1911): prostate cancer (Q181257)
• CSNK1D (Q15324798): increased expression in (P1911): Pick disease (Q18576)
• CSNK1D (Q15324798): increased expression in (P1911): progressive supranuclear palsy (Q945930)
• CSNK1D (Q15324798): increased expression in (P1911): Down syndrome (Q47715)
• CSNK1D (Q15324798): increased expression in (P1911): neurodegeneration (Q1755122)
• CSNK1D (Q15324798): increased expression in (P1911): Alzheimer's disease (Q11081)
• N-Terminal Propeptide of Type III Collagen (Q65948452): increased expression in (P1911): hyperthyroidism (Q16499)
• N-Terminal Propeptide of Type III Collagen (Q65948452): increased expression in (P1911): liver fibrosis (Q3071321)
• N-Terminal Propeptide of Type III Collagen (Q65948452): increased expression in (P1911): renal fibrosis (Q18553516)
• N-Terminal Propeptide of Type III Collagen (Q65948452): increased expression in (P1911): Crohn's disease (Q1472)
• Mid1 (Q18252303): gene deletion association with (P1912): Opitz-GBBB syndrome (Q3508750)

"Entity types" violations

Violations count: 0